Ingredient record · Nerve pain and seizure medicine
Gabapentin: bans, restrictions and failed batches in India
Last checked 3 November 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Sep 2026
2 entries containing Gabapentin are on India's banned-drugs list, and 1 is banned today. 21 batches of medicines containing Gabapentin failed a government lab test between August 2019 and September 2026, from 16 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
On the banned-drugs list
Gabapentin on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Gabapentin + Mecobalamin + Pyridoxine + ThiamineFixed-dose combination · vitamins | Banned | S.O. 4463(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Gabapentin + Mecobalamin + Pyridoxine + ThiamineFixed-dose combination · vitamins | Quashed | S.O. 798(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Gabapentin | 13 | 10 | Sep 2026 |
| Cyanocobalamin Calcium Pantothenate Gabapentin Pyridoxine Hcl Folic Acid | 1 | 1 | Aug 2026 |
| Gabapentin Nortriptyline Hydrochloride | 1 | 1 | May 2025 |
| Lidocaine Hydrochloride Gabapentin | 1 | 1 | Apr 2025 |
| Progaba | 1 | 1 | Apr 2025 |
| Gabapentin Amitriptyline Hcl | 1 | 1 | Nov 2023 |
| Gabon | 1 | 1 | Mar 2023 |
| Gebcare | 1 | 1 | Feb 2023 |
| Gabapentin Nortriptyline | 1 | 1 | Aug 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Gabapentin Tablets IP 300mg | Batch BHT-25021604Mfg Feb 2025 · Exp Jan 2027 | BON-HEUR PharmaceuticalsUttarakhand | The sample does not conform to the I.P. with respect to Dissolution.Dissolution | DTL, JodhpurState lab | Sep 2026 |
| Gabapentin Tablets IP 100 mg | Batch N2504093Mfg Dec 2025 · Exp Nov 2027 | Intas Pharmaceuticals Ltd.Samardung RoadSikkim | ASSAY OF GABAPENTIN I.P. ?Less than prescribed limit.Assay | SDTL, UttarakhandState lab | Sep 2026 |
| Cyanocobalamin, Calcium Pantothenate, Gabapentin, Pyridoxine Hcl & Folic Acid Tablets | Batch SGB.2504Mfg Dec 2025 · Exp Nov 2027 | Gothic pharmaceuticals pvt. LtdTelangana | Sample Does not meets the Specifications Wrt. Assay of GabapentinAssay | State Lab, DCL, TelanganaState lab | Aug 2026 |
| Gabapentin Tablets IP 300 mg | Batch TSF-DO897Mfg May 2025 · Exp Apr 2027 | Spen Formulations Pvt. Ltd | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab | May 2026 |
| Gabapentin capsules IP 400mg | Batch LPC25029Mfg Feb 2025 · Exp Jan 2027 | Levotic Pharma | Description and Uniformity of WeightDescription | SDTL, PunjabState lab | Feb 2026 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | Batch AFC2411056Mfg Nov 2024 · Exp Oct 2026 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 65.02% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | Batch AFC2501028Mfg Jan 2025 · Exp Dec 2026 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 68.50% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | Batch AFC2501029Mfg Jan 2025 · Exp Dec 2026 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 68.88% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | Batch AFC2502059Mfg Feb 2025 · Exp Jan 2027 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 71.22% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (GABATEC-300) | Batch SG2412559Mfg Dec 2024 · Exp Nov 2026 | Scout Lifescience Pvt. LtdHaryana | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab | May 2025 |
| Gabapentin & Nortriptyline Hydrochloride Tablets (GABVONT400) | Batch HT24642Mfg Dec 2024 · Exp Nov 2026 | HBC Healthcare Pvt. LtdGujarat | The sample does not confirm to the claim with respect to Assay of NortriptylineAssay | DTL,Jaipur (State Lab)State lab | May 2025 |
| Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | Batch PSWAB66Mfg Jun 2024 · Exp Nov 2025 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to Label claim with respect to the content of GabapentinLabelling | DTL MaduraiState lab | Apr 2025 |
| Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | Batch PWBBO7Mfg Jun 2024 · Exp Nov 2025 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to lebel claim with respect to the content of GabapentinOther | DTL MaduraiState lab | Apr 2025 |
| Gabapentin Tablets IP (Gabon-300) | Batch MT225040Mfg Nov 2022 · Exp Oct 2024 | Mascot Health Series Pvt. LtdUttarakhand | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Apr 2024 |
| Gabapentin & Amitriptyline HCl Tablets (GABAMER AT) | Batch T-230420Mfg Apr 2023 · Exp Mar 2025 | Vilin Bio Med LtdUttarakhand | Assay of Amitriptyline HydrochlorideAssay | CDL KolkataCDSCO lab | Nov 2023 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.